Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$447K Sell
8,535
-1,772
-17% -$93.7K 0.23% 77
2026
Q1
$569K Sell
10,307
-1,923
-16% -$104K 0.34% 63
2025
Q4
$600K Buy
12,230
+202
+2% +$9.42K 0.39% 56
2025
Q3
$531K Buy
+12,028
New +$470K 0.35% 64

Other funds holding GSK

Code Waechter's GSK Position: Q2 2026 in Review

Code Waechter reduced its GSK (GSK) stake by 17% in Q2 2026, selling an estimated $93.7K and leaving 8,535 shares worth $447K. The position accounts for 0.23% of the portfolio, ranked #77.

Code Waechter first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $600K in Q4 2025. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Code Waechter held 8,535 shares of GSK worth $447K as of Q2 2026.
  • Code Waechter sold 1,772 GSK shares in Q2 2026, an estimated $93.7K.
  • GSK made up 0.23% of Code Waechter's portfolio in Q2 2026, its #77 holding.
  • Code Waechter first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • Code Waechter's GSK position peaked at $600K in Q4 2025.
  • 1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Code Waechter's 13F filing for Q2 2026, filed 31 Jul 2026.